October 29, 2008
Westin Gaslamp Quarter Hotel
San Diego, CA
The Global Regulatory Summit was developed by the International Society for Biological Therapy of Cancer (iSBTc) to bring together the knowledge and insight of thought leaders at regulatory agencies from around the world to give a global perspective on regulatory considerations in the development of oncology biologics products for the treatment of cancer. iSBTc as a society, and in particular through its educational programming, has evolved into a premier venue for scientific exchange and collaborative interaction among investigators from academia, industry, and regulatory agencies in the U.S. and abroad with a specific focus on tumor immunology and the biological therapy of cancer.
The purpose of the Global Regulatory Summit is to provide the audience with key information from regulatory agencies from various regions of the world in oncology biologics product development. The attendees of this program will learn about and participate in the discussion of a variety of specific regulatory considerations and requirements. The presentations will address those requirements and considerations especially pertaining to product, pre-clinical and clinical trial issues for oncology biologics products.